Genetic and functional evaluation of the role of DLL1 in susceptibility to visceral leishmaniasis in India

Infection, Genetics and Evolution

Volumn 12, Issue 6, 2012, Pages 1195-1201

  Mehrotra, Sanjana ^a   Fakiola, Michaela ^b,c   Mishra, Anshuman ^a   Sudarshan, Medhavi ^a   Tiwary, Puja ^a   Rani, Deepa Selvi ^d   Thangaraj, Kumarasamy ^d   Rai, Madhukar ^a   Sundar, Shyam ^a   Blackwell, Jenefer M ^b,c  

^a BANARAS HINDU UNIVERSITY   (India)

^b UNIVERSITY OF WESTERN AUSTRALIA   (Australia)

^c UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^d CENTRE FOR CELLULAR AND MOLECULAR BIOLOGY   (India)

Author keywords

DLL1; Genetic association; Notch signalling; Visceral leishmaniasis

Indexed keywords

ADULT; ARTICLE; CHROMOSOME 6Q; CONTROLLED STUDY; DISEASE PREDISPOSITION; DLL1 GENE; FAM120B GENE; FEMALE; GENE; GENE EXPRESSION; GENE FREQUENCY; GENE FUNCTION; GENETIC ASSOCIATION; GENETIC RISK; GENETIC SUSCEPTIBILITY; GENETIC VARIABILITY; GENOTYPE; HAPLOTYPE; HUMAN; HUMAN TISSUE; INDIA; INTRON; MAJOR CLINICAL STUDY; MALE; PATHOGENESIS; POPULATION RESEARCH; POPULATION STRUCTURE; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SINGLE NUCLEOTIDE POLYMORPHISM; SPLEEN BIOPSY; VISCERAL LEISHMANIASIS;

ADOLESCENT; ADULT; CASE-CONTROL STUDIES; FEMALE; GENETIC PREDISPOSITION TO DISEASE; HAPLOTYPES; HUMANS; INDIA; INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS; LEISHMANIASIS, VISCERAL; LINKAGE DISEQUILIBRIUM; LOGISTIC MODELS; MALE; MEMBRANE PROTEINS; MIDDLE AGED; MODELS, GENETIC; POLYMORPHISM, SINGLE NUCLEOTIDE; RECEPTORS, NOTCH; SPLEEN;

EID: 84861943570     PISSN: 15671348     EISSN: 15677257     Source Type: Journal    
DOI: 10.1016/j.meegid.2012.04.017     Document Type: Article

References (33)

1. Amsen D., Blander J.M., Lee G.R., Tanigaki K., Honjo T., Flavell R.A. Instruction of distinct CD4 T helper cell fates by different notch ligands on antigen-presenting cells. Cell 2004, 117:515-526.
2. Artavanis-Tsakonas S., Rand M.D., Lake R.J. Notch signaling: cell fate control and signal integration in development. Science 1999, 284:770-776.
3. Badaro R., Jones T.C., Carvalho E.M., Sampaio D., Reed S.G., Barral A., Teixeira R., Johnson W.D. New perspectives on a subclinical form of visceral leishmaniasis. J. Infect. Dis. 1986, 154:1003-1011.
4. Barral-Netto M., Badaro R., Barral A., Almeida R.P., Santos S.B., Badaro F., Pedral-Sampaio D., Carvalho E.M., Falcoff E., Falcoff R. Tumor necrosis factor (cachectin) in human visceral leishmaniasis. J. Infect. Dis. 1991, 163:853-857.
5. Barrett J.C., Fry B., Maller J., Daly M.J. Haploview: analysis and visualization of LD and haplotype maps. Bioinformatics 2005, 21:263-265.
6. Blackwell J.M., Fakiola M., Ibrahim M.E., Jamieson S.E., Jeronimo S.B., Miller E.N., Mishra A., Mohamed H.S., Peacock C.S., Raju M., Sundar S., Wilson M.E. Genetics and visceral leishmaniasis: of mice and man. Parasite Immunol. 2009, 31:254-266.
7. Carvalho E.M., Barral A., Pedral-Sampaio D., Barral-Netto M., Badaro R., Rocha H., Johnson W.D. Immunologic markers of clinical evolution in children recently infected with Leishmania donovani chagasi. J. Infect. Dis. 1992, 165:535-540.
8. Dudbridge F. Likelihood-based association analysis for nuclear families and unrelated subjects with missing genotype data. Hum. Hered. 2008, 66:87-98.
9. Dudbridge F., Holmans P.A., Wilson S.G. A flexible model for association analysis in sibships with missing genotype data. Ann. Hum. Genet. 2011, 75:428-438.
10. Fakiola M., Miller E.N., Fadl M., Mohamed H.S., Jamieson S.E., Francis R.W., Cordell H.J., Peacock C.S., Raju M., Khalil E.A., Elhassan A., Musa A.M., Silveira F., Shaw J.J., Sundar S., Jeronimo S.M., Ibrahim M.E., Blackwell J.M. Genetic and functional evidence implicating DLL1 as the gene that influences susceptibility to visceral leishmaniasis at chromosome 6q27. J. Infect. Dis. 2011, 204:467-477.
11. Fakiola M., Mishra A., Rai M., Singh S.P., O'Leary R.A., Ball S., Francis R.W., Firth M.J., Radford B.T., Miller E.N., Sundar S., Blackwell J.M. Classification and regression tree and spatial analyses reveal geographic heterogeneity in genome wide linkage study of Indian visceral leishmaniasis. PLoS ONE 2010, 5:e15807.
12. Gabriel S.B., Schaffner S.F., Nguyen H., Moore J.M., Roy J., Blumenstiel B., Higgins J., DeFelice M., Lochner A., Faggart M., Liu-Cordero S.N., Rotimi C., Adeyemo A., Cooper R., Ward R., Lander E.S., Daly M.J., Altshuler D. The structure of haplotype blocks in the human genome. Science 2002, 296:2225-2229.
13. Gidwani K., Jones S., Kumar R., Boelaert M., Sundar S. Interferon-gamma release assay (modified QuantiFERON) as a potential marker of infection for Leishmania donovani, a proof of concept study. PLoS Negl. Trop. Dis. 2011, 5:e1042.
14. Greenwald I. LIN-12/Notch signaling: lessons from worms and flies. Genes Dev. 1998, 12:1751-1762.
15. Jaleco A.C., Neves H., Hooijberg E., Gameiro P., Clode N., Haury M., Henrique D., Parreira L. Differential effects of Notch ligands Delta-1 and Jagged-1 in human lymphoid differentiation. J. Exp. Med. 2001, 194:991-1002.
16. Jamieson S.E., Miller E.N., Peacock C.S., Fakiola M., Wilson M.E., Bales-Holst A., Shaw M.A., Silveira F., Shaw J.J., Jeronimo S.M., Blackwell J.M. Genome-wide scan for visceral leishmaniasis susceptibility genes in Brazil. Genes Immun. 2007, 8:84-90.
17. Jennewein C., Kuhn A.M., Schmidt M.V., Meilladec-Jullig V., von Knethen A., Gonzalez F.J., Brune B. Sumoylation of peroxisome proliferator-activated receptor gamma by apoptotic cells prevents lipopolysaccharide-induced NCoR removal from kappaB binding sites mediating transrepression of proinflammatory cytokines. J. Immunol. 2008, 181:5646-5652.
18. Li D., Kang Q., Wang D.M. Constitutive coactivator of peroxisome proliferator-activated receptor (PPARgamma), a novel coactivator of PPARgamma that promotes adipogenesis. Mol. Endocrinol. 2007, 21:2320-2333.
19. Locksley R.M., Scott P. Helper T-cell subsets in mouse leishmaniasis induction, expansion and effector function. Immunol. Today 1991, 12:A58-A61.
20. Maekawa Y., Tsukumo S., Chiba S., Hirai H., Hayashi Y., Okada H., Kishihara K., Yasutomo K. Delta1-Notch3 interactions bias the functional differentiation of activated CD4+ T cells. Immunity 2003, 19:549-559.
21. Mehrotra S., Oommen J., Mishra A., Sudharshan M., Tiwary P., Jamieson S.E., Fakiola M., Rani D.S., Thangaraj K., Rai M., Sundar S., Blackwell J.M. No evidence for association between SLC11A1 and visceral leishmaniasis in India. BMC Med. Genet. 2011, 12:71.
22. Miller E.N., Fadl M., Mohamed H.S., El Zein A., Jamieson S.E., Cordell H.J., Peacock C.S., Fakiola M., Raju M., Khalil E.A., El Hassan A.M., Ibrahim M.E., Blackwell J.M. Y chromosome lineage- and village-specific genes on chromosomes 1p22 and 6q27 that control visceral leishmaniasis in The Sudan. PLoS Genet. 2007, 3:679-688.
23. Ohishi K., Varnum-Finney B., Serda R.E., Anasetti C., Bernstein I.D. The Notch ligand, Delta-1, inhibits the differentiation of monocytes into macrophages but permits their differentiation into dendritic cells. Blood 2001, 98:1402-1407.
24. Pirmez C., Yamamura M., Uyemura K., Paes-Oliveira M., Modlin R.L. Cytokine patterns in the pathogenesis of human leishmaniasis. J. Clin. Invest. 1993, 91:1390-1395.
25. Purcell S., Neale B., Todd-Brown K., Thomas L., Ferreira M.A., Bender D., Maller J., Sklar P., de Bakker P.I., Daly M.J., Sham P.C. PLINK: a tool set for whole-genome association and population-based linkage analyses. Am. J. Hum. Genet. 2007, 81:559-575.
26. Sacks D.L., Lal S.L., Shrivastava S.N., Blackwell J.M., Neva F.A. An analysis of T cell responsiveness in Indian Kala-azar. J. Immunol. 1987, 138:908-913.
27. Scott P., Pearce E., Cheever A.W., Coffman R.L., Sher A. Role of cytokines and CD4+ T-cell subsets in the regulation of parasite immunity and disease. Immunol. Rev. 1989, 112:162-182.
28. Sekine C., Moriyama Y., Koyanagi A., Koyama N., Ogata H., Okumura K., Yagita H. Differential regulation of splenic CD8- dendritic cells and marginal zone B cells by Notch ligands. Int. Immunol. 2009, 21:295-301.
29. Singh S.P., Reddy D.C., Mishra R.N., Sundar S. Knowledge, attitude, and practices related to Kala-azar in a rural area of Bihar state, India. Am. J. Trop. Med. Hyg. 2006, 75:505-508.
30. Sundar S., Benjamin B. Diagnosis and treatment of Indian visceral leishmaniasis. J. Assoc. Physicians India 2003, 51:195-201.
31. Sundar S., Reed S.G., Sharma S., Mehrotra A., Murray H.W. Circulating T helper 1 (Th1) cell- and Th2 cell-associated cytokines in Indian patients with visceral leishmaniasis. Am. J. Trop. Med. Hyg. 1997, 56:522-525.
32. Topno R.K., Das V.N., Ranjan A., Pandey K., Singh D., Kumar N., Siddiqui N.A., Singh V.P., Kesari S., Bimal S., Kumar A.J., Meena C., Kumar R., Das P. Asymptomatic infection with visceral leishmaniasis in a disease-endemic area in Bihar. India. Am. J. Trop. Med. Hyg. 2010, 83:502-506.
33. Zijlstra E.E., el-Hassan A.M., Ismael A. Endemic kala-azar in eastern Sudan: post-kala-azar dermal leishmaniasis. Am. J. Trop. Med. Hyg. 1995, 52:299-305.